3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Wilms Tumor
1
Stomatitis
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Mucositis
1
Mouth Neoplasms
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Dendritic Cell Sarcoma, Interdigitating
1
Burkitt Lymphoma
1
Interventions
Radiotherapy
8
Cisplatin
8
Cetuximab
8
pembrolizumab
5
Fluorouracil
5
Drug Therapy
5
Surveys and Questionnaires
4
Celecoxib
4
Radiotherapy, Intensity-Modulated
3
Radiation
3
Sentinel Lymph Node Biopsy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Physical Therapy Modalities
2
Nicotine
2
Interviews as Topic
2
Injections
2
Immunohistochemistry
2
High-Energy Shock Waves
2
Counseling
2
Chemoradiotherapy
2
Bupropion
2
Aminolevulinic Acid
2
trametinib
1
traY protein, E coli
1
toripalimab
1
sodium thiosulfate
1
sargramostim
1
motexafin gadolinium
1
mogamulizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mouth Neoplasms
×
Traumeel S
×
Clear all
NCT00584597
2010-12-13
TRAUMEEL
University of Oklahoma
Phase 1
Completed
14 enrolled